<DOC>
	<DOCNO>NCT03104816</DOCNO>
	<brief_summary>Simple explanation rationale : Recovery spine surgery usually accompany severe pain traditionally manage opioids . It common practice supplement opioid treatment different class analgesic work alternative pain pathway receptor order achieve additive synergistic effect reduce amount opioids necessary pain control . Acetaminophen beneficial supplemental analgesic opioids postoperative pain relief . Intervention : Patients randomize either treatment IV acetaminophen ( A ) , PO acetaminophen ( B ) , hydromorphone control group ( C ) . Objective/Purpose : Primary objective determine impact administer supplemental non-opioid analgesic drug IV PO acetaminophen total opioid dose administer perioperative period . Secondary objective include investigate impact IV/PO acetaminophen level postoperative pain , patient satisfaction , side effect secondary opioids nausea , vomit , pruritus , sedation , respiratory depression , ileus , urinary retention , PACU discharge time . Study population : 126 patient enrol study ( 42 group A , 42 group B , 42 control group C ) . Follow-up Endpoints / Outcomes : Postoperative assessment do 0 , 30 , 60 minute , 6 hour , 12 hour 24 hour surgery . Patients evaluate pain ( use numeric rating scale ) , total opioid consumption , opioid side effect include drowsiness ( use Ramsey sedation scale Aldrete score time arrival discharge recovery room ) , respiratory depression , nausea , vomit , pruritus . Patient satisfaction also assess use numeric rating scale .</brief_summary>
	<brief_title>The Effectiveness IV/PO Acetaminophen Perioperative Period Reducing Opiate Use After Lumbar Spine Fusion</brief_title>
	<detailed_description>Simple explanation rationale : Recovery spine surgery , especially spinal fusion surgery , usually accompany severe pain traditionally manage opioids . While opioids proven effective , associate undesirable side effect include nausea , vomit , pruritus , sedation , respiratory depression , ileus , urinary retention lead increased time require recovery decrease patient satisfaction . For reason , common practice supplement opioid treatment different class analgesic work alternative pain pathway receptor order achieve additive synergistic effect reduce amount opioids necessary pain control . Acetaminophen centrally-acting cyclooxygenase inhibitor nonsteroidal anti-inflammatory medication minimal , , gastrointestinal platelet-inhibiting side effect , well tolerate patient cyclooxygenase inhibitor . This medication beneficial supplemental analgesic opioids postoperative pain relief . Previously conduct study demonstrate rationale use intravenous/PO acetaminophen multimodal analgesic regimen reduce postoperative analgesia . Intervention : Patients randomize either treatment IV acetaminophen ( A ) , PO acetaminophen ( B ) , hydromorphone control group ( C ) . Patients randomize group A receive 1 g IV acetaminophen wound closure every 4 6 hour postoperatively total 4 g 24 hour . Patients randomize group B receive 1 g PO acetaminophen surgery every 4 6 hour postoperatively total 4 g 24 hour . Patients randomize control group C receive acetaminophen . Post-operatively , patient group also receive IV hydromorphone PCA 24 hour pain . Objective/Purpose : Primary objective determine impact administer supplemental non-opioid analgesic drug IV PO acetaminophen total opioid dose administer perioperative period . Secondary objective include investigate impact IV/PO acetaminophen level postoperative pain , patient satisfaction , side effect secondary opioids nausea , vomit , pruritus , sedation , respiratory depression , ileus , urinary retention , PACU discharge time . Study population : 126 patient enrol study ( 42 group A , 42 group B , 42 control group C ) . Follow-up Endpoints / Outcomes : Postoperative assessment do 0 , 30 , 60 minute , 6 hour , 12 hour 24 hour surgery . Patients evaluate pain ( use numeric rating scale ) , total opioid consumption , opioid side effect include drowsiness ( use Ramsey sedation scale Aldrete score time arrival discharge recovery room ) , respiratory depression , nausea , vomit , pruritus . Patient satisfaction also assess use numeric rating scale . Statistics : All sample size calculation reference : - Specific Aim 1 reduction opioid intake least 25 % Control ( Group C ) Intervention Groups A B , - Specific Aim 2 improvement Pain Score least 25 % Control ( Group C ) Intervention Groups A B ,</detailed_description>
	<mesh_term>Hydromorphone</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>ASA IIII patient schedule elective one two level minimally invasive lumbar fusion Patients require surgery neoplastic process Allergy acetaminophen Liver dysfunction elevate Liver Function Tests ( LFTs ) Alcohol drug dependency Mental retardation Less 50 kg weight regnant woman Patients require longacting opioid pain management ( include fentanyl patch , oxycontin , etc ) 3 week immediately prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Acetaminophen po</keyword>
	<keyword>Acetaminophen IV</keyword>
	<keyword>Pain management</keyword>
	<keyword>minimally invasive lumbar fusion</keyword>
	<keyword>Ofirmev</keyword>
	<keyword>Analgesics</keyword>
	<keyword>Opioid</keyword>
	<keyword>Pain</keyword>
	<keyword>Postoperative</keyword>
	<keyword>Spinal</keyword>
</DOC>